Page 5 - Clinical Evolution News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ObvioHealth announces upgraded decentralized trial platform The company’s technology facilitates remote patient monitoring and integrates with a wide range of wearable sensors for checking patient vital signs. ObvioHealth has introduced a new platform that enables advanced remote-patient monitoring capabilities for decentralized trial solutions. The company’s decentralized platform and patient-centric smartphone app are designed to help create an ‘ecosystem’ of technology and devices approved by the US Food and Drug Administration (FDA) to support remote mo...

A leader from Vocalis Health explains how health data can be culled from patient voice recordings to screen and monitor COVID-19 and other conditions. OSP: Could you please share the ‘elevator presentation’ description of Vocalis—who you are, what you do, and what sets you apart?​ SH: Vocalis Health is an AI health tech company pioneering the development of vocal biomarkers – where health-related information is derived from analysis of people’s voice recordings – to screen, detect, monitor and predict health symptoms, conditions and diseases.  In 201...

According to Noxopharm, a recent study shows combining its Veyonda drug and a radiopharmaceutical yields favorable results against prostate cancer. Noxopharm has released the most recent survival data from its LuPIN prostate cancer study. The company reports results show a median overall survival (mOS) of 19.7 months, higher than all other mOS results for existing prostate cancer treatments in their own registration studies. These findings reportedly support evidence that a combination of Veyonda (NOX66) and experimental radiopharmaceutical 177lutetium-PSMA-617 cou...

The Verisense Pulse+ can measure heart rate, oxygen saturation, emotional responses, and activity and sleep levels of at-home clinical trial participants. Shimmer Research has announced its Verisense Pulse+ sensor for use with its Verisense wearable sensor platform. The device is designed to offer photoplethysmogram (PPG), galvanic skin response (GSR), and inertial measurement unit (IMU). According to the company, the PPG sensor monitors heart rate by using light absorption to measure changes in capillary blood volume. The GSR sensor measures changes in sweat-gland...

A leader from the genetic solutions firm explains how genetic testing and counseling can help trial teams form more beneficial connections with patients. Patient identification, recruitment and engagement are a struggle with any trial, no matter the condition at the center of the research. When the planned study involves a rare disease, the obstacles become even more formidable, thanks to a smaller population to find and draw from, patients scattered all over the country (or even the globe), and people with the disease in question are more likely to be faced with m...